pubmed tirzepatide Weight Loss Efficacy of Compared to Placebo or GLP-1 Receptor Agonists in Adults With Obesity or Overweight: A Meta-Analysis of Randomized Controlled Trials With ≥ 20 Weeks Treatment Duration Tirzepatide Dosing: Diabetes vs Weight
Description
Personal or family history of gout is the most significant predictor, as these individuals already have a predisposition to elevated uric acid levels or impaired uric acid handling
The tirzepatide cohort also had a reduced need for pars plana vitrectomy, but it did not reach significance
As early as clinically appropriate
One such challenge is that GLP-1s are designed to be taken for the long-term, however, up to 68% of people have discontinued their treatment as soon as one year later
